• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

依从性阈值在直接口服抗凝药依从性预测模型的开发和性能方面的作用

The Role of Adherence Thresholds for Development and Performance Aspects of a Prediction Model for Direct Oral Anticoagulation Adherence.

作者信息

Ruff Carmen, Koukalova Ludmila, Haefeli Walter E, Meid Andreas D

机构信息

Department of Clinical Pharmacology and Pharmacoepidemiology, University of Heidelberg, Heidelberg, Germany.

出版信息

Front Pharmacol. 2019 Feb 19;10:113. doi: 10.3389/fphar.2019.00113. eCollection 2019.

DOI:10.3389/fphar.2019.00113
PMID:30837879
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6389873/
Abstract

Patients who do not sufficiently adhere to their dosing regimens will, ultimately, do not get the full benefit of their medication. For example, if direct oral anticoagulants (DOAC) are not taken continuously, an intervention to improve adherence or maintain persistence will show direct effects on clinical outcomes. Usually, adherent patients are defined by taking ≥80% of their medication. The resulting binary adherence status from this threshold can as well be used for predictive classification. Thus, the threshold can determine the prediction model's performance to identify patients at risk for poor adherence by this binary adherence status. In this perspective, we propose a plan for model development and performance considering the threshold's role. Concerning development demands, we extracted predictors from a systematic literature search on DOAC adherence to be used as a core set of candidate predictors. Independently, we investigated how well a future model would technically have to perform by modeling drug intake and thromboembolic events based on a rivaroxaban pharmacokinetic-pharmacodynamic model. Using this simulation framework for different thresholds, we projected the impact of an imperfectly predicted adherence status on the event risk, and how imperfect sensitivity and specificity affect the cost balance if a supporting intervention was offered to patients classified as non-adherent. Our simulation results suggest applying a rather high threshold (90%) for discrimination between patients at low or high risk for non-adherence by a prediction model in order to assure cost-efficient implementation.

摘要

未充分遵守给药方案的患者最终无法充分受益于其药物治疗。例如,如果直接口服抗凝剂(DOAC)未持续服用,改善依从性或维持持续性的干预措施将对临床结果产生直接影响。通常,依从性好的患者被定义为服用了≥80%的药物。由此阈值产生的二元依从性状态也可用于预测分类。因此,该阈值可以确定预测模型通过这种二元依从性状态识别依从性差风险患者的性能。从这个角度来看,我们提出了一个考虑阈值作用的模型开发和性能计划。关于开发要求,我们通过对DOAC依从性的系统文献检索提取预测因子,用作候选预测因子的核心集。独立地,我们通过基于利伐沙班药代动力学-药效学模型对药物摄入和血栓栓塞事件进行建模,研究了未来模型在技术上需要达到的性能水平。使用这个针对不同阈值的模拟框架,我们预测了预测的依从性状态不完美对事件风险的影响,以及如果对被分类为不依从的患者提供支持性干预,不完美的敏感性和特异性如何影响成本平衡。我们的模拟结果表明,为了确保成本效益高的实施,预测模型应采用相对较高的阈值(90%)来区分低或高不依从风险的患者。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df09/6389873/b57a2c898370/fphar-10-00113-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df09/6389873/789100ef4202/fphar-10-00113-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df09/6389873/b57a2c898370/fphar-10-00113-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df09/6389873/789100ef4202/fphar-10-00113-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/df09/6389873/b57a2c898370/fphar-10-00113-g002.jpg

相似文献

1
The Role of Adherence Thresholds for Development and Performance Aspects of a Prediction Model for Direct Oral Anticoagulation Adherence.依从性阈值在直接口服抗凝药依从性预测模型的开发和性能方面的作用
Front Pharmacol. 2019 Feb 19;10:113. doi: 10.3389/fphar.2019.00113. eCollection 2019.
2
Real-World Adherence and Persistence with Direct Oral Anticoagulants in Adults with Atrial Fibrillation.真实世界中成人房颤患者直接口服抗凝药物的依从性和持久性。
Pharmacotherapy. 2017 Oct;37(10):1221-1230. doi: 10.1002/phar.1989. Epub 2017 Sep 6.
3
Real-World Adherence and Persistence to Direct Oral Anticoagulants in Patients With Atrial Fibrillation: A Systematic Review and Meta-Analysis.心房颤动患者对直接口服抗凝剂的真实世界依从性和持续性:一项系统评价和荟萃分析。
Circ Cardiovasc Qual Outcomes. 2020 Mar;13(3):e005969. doi: 10.1161/CIRCOUTCOMES.119.005969. Epub 2020 Mar 9.
4
Comparison of Prescribing Practices with Direct Acting Oral Anticoagulant Protocols.直接口服抗凝药物治疗方案的处方实践比较。
Am J Cardiovasc Drugs. 2017 Dec;17(6):475-479. doi: 10.1007/s40256-017-0243-2.
5
Medication taking behaviors in patients taking warfarin versus direct oral anticoagulants: A systematic review.服用华法林与直接口服抗凝剂患者的用药行为:一项系统评价。
Expert Rev Cardiovasc Ther. 2019 Jun;17(6):427-434. doi: 10.1080/14779072.2019.1620600. Epub 2019 May 29.
6
Adherence and outcomes to direct oral anticoagulants among patients with atrial fibrillation: findings from the veterans health administration.心房颤动患者使用直接口服抗凝剂的依从性及治疗结果:退伍军人健康管理局的研究发现
BMC Cardiovasc Disord. 2017 Sep 2;17(1):236. doi: 10.1186/s12872-017-0671-6.
7
Predictors of self-reported adherence to direct oral anticoagulation in a population of elderly men and women with non-valvular atrial fibrillation.老年非瓣膜性心房颤动患者自我报告的直接口服抗凝剂依从性的预测因素。
J Thromb Thrombolysis. 2018 Aug;46(2):139-144. doi: 10.1007/s11239-018-1679-1.
8
A Systematic Review of Medication Adherence Thresholds Dependent of Clinical Outcomes.对依赖临床结果的药物依从性阈值的系统评价。
Front Pharmacol. 2018 Nov 20;9:1290. doi: 10.3389/fphar.2018.01290. eCollection 2018.
9
Patient-level adherence and interventions in an interdisciplinary DOAC clinic.在一个多学科 DOAC 门诊中患者的依从性和干预措施。
Thromb Res. 2019 Jul;179:34-36. doi: 10.1016/j.thromres.2019.04.021. Epub 2019 Apr 22.
10

引用本文的文献

1
Electronic Monitoring of Medication Adherence to Direct Oral Anticoagulants: A Systematic Review.直接口服抗凝剂药物依从性的电子监测:一项系统评价
Patient Prefer Adherence. 2025 Apr 7;19:921-939. doi: 10.2147/PPA.S505485. eCollection 2025.
2
Intake Patterns and Experiences of Patients Using Direct Oral Anticoagulants Measured by Electronic Monitoring in Community Pharmacies.在社区药房通过电子监测测量使用直接口服抗凝剂患者的用药模式和体验。
Patient Prefer Adherence. 2024 Nov 6;18:2225-2234. doi: 10.2147/PPA.S469910. eCollection 2024.
3
Medication Adherence to Direct Oral Anticoagulants: Extent and Impact of Side Effects.

本文引用的文献

1
Discontinuation risk comparison among 'real-world' newly anticoagulated atrial fibrillation patients: Apixaban, warfarin, dabigatran, or rivaroxaban.真实世界中新抗凝治疗的心房颤动患者停药风险比较:阿哌沙班、华法林、达比加群或利伐沙班。
PLoS One. 2018 Apr 30;13(4):e0195950. doi: 10.1371/journal.pone.0195950. eCollection 2018.
2
Secondary adherence to non-vitamin-K antagonist oral anticoagulants in patients with atrial fibrillation in Sweden and the Netherlands.瑞典和荷兰房颤患者非维生素 K 拮抗剂口服抗凝剂的二次依从性。
Curr Med Res Opin. 2018 Oct;34(10):1839-1847. doi: 10.1080/03007995.2018.1459528. Epub 2018 May 3.
3
直接口服抗凝剂的药物依从性:副作用的程度及影响
Patient Prefer Adherence. 2024 Aug 23;18:1779-1788. doi: 10.2147/PPA.S463164. eCollection 2024.
4
Sequential model for predicting patient adherence in subcutaneous immunotherapy for allergic rhinitis.预测过敏性鼻炎皮下免疫治疗中患者依从性的序贯模型
Front Pharmacol. 2024 Jul 19;15:1371504. doi: 10.3389/fphar.2024.1371504. eCollection 2024.
5
A prediction model for nonpersistence or nonadherence to direct oral anticoagulants in hospitalized patients with atrial fibrillation.预测模型:评估住院房颤患者不持续或不遵从直接口服抗凝药物治疗的情况。
J Manag Care Spec Pharm. 2022 Oct;28(10):1161-1172. doi: 10.18553/jmcp.2022.28.10.1161.
6
Can Machine Learning from Real-World Data Support Drug Treatment Decisions? A Prediction Modeling Case for Direct Oral Anticoagulants.基于真实世界数据的机器学习能否支持药物治疗决策?直接口服抗凝药物的预测模型案例。
Med Decis Making. 2022 Jul;42(5):587-598. doi: 10.1177/0272989X211064604. Epub 2021 Dec 15.
7
Estimated Thresholds of Minimum Necessary Adherence for Effective Treatment with Direct Oral Anticoagulants - A Retrospective Cohort Study in Health Insurance Claims Data.直接口服抗凝剂有效治疗的最低必要依从性估计阈值——基于健康保险理赔数据的回顾性队列研究
Patient Prefer Adherence. 2021 Sep 24;15:2209-2220. doi: 10.2147/PPA.S324315. eCollection 2021.
8
Design and rationale of DUTCH-AF: a prospective nationwide registry programme and observational study on long-term oral antithrombotic treatment in patients with atrial fibrillation.DUTCH-AF 的设计与原理:一项关于心房颤动患者长期口服抗血栓治疗的前瞻性全国注册研究计划和观察性研究。
BMJ Open. 2020 Aug 24;10(8):e036220. doi: 10.1136/bmjopen-2019-036220.
9
Economic evaluations of big data analytics for clinical decision-making: a scoping review.大数据分析在临床决策中的经济评价:范围综述。
J Am Med Inform Assoc. 2020 Jul 1;27(9):1466-1475. doi: 10.1093/jamia/ocaa102.
The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation.
2018 年欧洲心脏病学会关于非维生素 K 拮抗剂口服抗凝剂在心房颤动患者中应用的实用指南。
Eur Heart J. 2018 Apr 21;39(16):1330-1393. doi: 10.1093/eurheartj/ehy136.
4
Risk of Recurrent Ischemic Stroke with Unintended Low-Dose Oral Anticoagulant Therapy and Optimal Timing of Review.非预期低剂量口服抗凝治疗复发性缺血性卒中的风险及最佳复查时机。
J Stroke Cerebrovasc Dis. 2018 Jun;27(6):1546-1551. doi: 10.1016/j.jstrokecerebrovasdis.2018.01.002. Epub 2018 Feb 1.
5
Oral anticoagulant persistence in patients with non-valvular atrial fibrillation: A cohort study using primary care data in Germany.非瓣膜性心房颤动患者口服抗凝药的持续性:一项使用德国初级保健数据的队列研究。
PLoS One. 2017 Oct 10;12(10):e0185642. doi: 10.1371/journal.pone.0185642. eCollection 2017.
6
The myths of medication adherence.药物依从性的误区。
Pharmacoepidemiol Drug Saf. 2017 Dec;26(12):1437-1441. doi: 10.1002/pds.4334. Epub 2017 Oct 10.
7
Adherence to Rivaroxaban, Dabigatran, and Apixaban for Stroke Prevention for Newly Diagnosed and Treatment-Naive Atrial Fibrillation Patients: An Update Using 2013-2014 Data.新诊断且未经治疗的房颤患者使用利伐沙班、达比加群和阿哌沙班预防卒中的依从性:基于 2013-2014 年数据的更新。
J Manag Care Spec Pharm. 2017 Sep;23(9):958-967. doi: 10.18553/jmcp.2017.23.9.958.
8
Adherence to Rivaroxaban Compared with Other Oral Anticoagulant Agents Among Patients with Nonvalvular Atrial Fibrillation.非瓣膜性心房颤动患者中利伐沙班与其他口服抗凝药物的依从性比较。
J Manag Care Spec Pharm. 2017 Sep;23(9):980-988. doi: 10.18553/jmcp.2017.23.9.980.
9
Real-World Adherence and Persistence with Direct Oral Anticoagulants in Adults with Atrial Fibrillation.真实世界中成人房颤患者直接口服抗凝药物的依从性和持久性。
Pharmacotherapy. 2017 Oct;37(10):1221-1230. doi: 10.1002/phar.1989. Epub 2017 Sep 6.
10
Non-vitamin K antagonist oral anticoagulants: impact of non-adherence and discontinuation.非维生素K拮抗剂口服抗凝药:不依从和停药的影响
Expert Opin Drug Saf. 2017 Sep;16(9):1051-1062. doi: 10.1080/14740338.2017.1351542. Epub 2017 Jul 12.